Bax Inhibitor 1 in apoptosis and disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ahn T, Yun CH, Chae HZ, Kim HR, Chae HJ . (2009). Ca2+/H+ antiporter-like activity of human recombinant Bax inhibitor-1 reconstituted into liposomes. FEBS J 276: 2285–2291.
Ahn T, Yun CH, Kim HR, Chae HJ . (2010). Cardiolipin, phosphatidylserine, and BH4 domain of Bcl-2 family regulate Ca2+/H+ antiporter activity of human Bax inhibitor-1. Cell Calcium 47: 387–396.
Bailly-Maitre B, Fondevila C, Kaldas F, Droin N, Luciano F, Ricci JE et al. (2006). Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury. Proc Natl Acad Sci USA 103: 2809–2814.
Burns TF, El-Deiry WS . (2001). Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. J Biol Chem 276: 37879–37886.
Cande C, Cecconi F, Dessen P, Kroemer G . (2002). Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J Cell Sci 115: 4727–4734.
Caron E, Crepin VF, Simpson N, Knutton S, Garmendia J, Frankel G . (2006). Subversion of actin dynamics by EPEC and EHEC. Curr Opin Microbiol 9: 40–45.
Chae HJ, Kim HR, Xu C, Bailly-Maitre B, Krajewska M, Krajewski S et al. (2004). BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Mol Cell 15: 355–366.
Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR . (2010). The BCL-2 family reunion. Mol Cell 37: 299–310.
Circu ML, Aw TY . (2010). Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48: 749–762.
Crane JK, McNamara BP, Donnenberg MS . (2001). Role of EspF in host cell death induced by enteropathogenic Escherichia coli. Cell Microbiol 3: 197–211.
del Carmen Garcia Molina Wolgien M, da Silva ID, Villanova FE, Yumi Otsuka A, Borra RC, Lima Reis LF et al. (2005). Differential gene expression assessed by cDNA microarray analysis in breast cancer tissue under tamoxifen treatment. Eur J Gynaecol Oncol 26: 501–504.
Grzmil M, Kaulfuss S, Thelen P, Hemmerlein B, Schweyer S, Obenauer S et al. (2006). Expression and functional analysis of Bax inhibitor-1 in human breast cancer cells. J Pathol 208: 340–349.
Hemrajani C, Berger CN, Robinson KS, Marches O, Mousnier A, Frankel G . (2010). NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc Natl Acad Sci USA 107: 3129–3134.
Hetz C, Bernasconi P, Fisher J, Lee AH, Bassik MC, Antonsson B et al. (2006). Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha. Science 312: 572–576.
Igney FH, Krammer PH . (2002). Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2: 277–288.
Imaizumi K, Miyoshi K, Katayama T, Yoneda T, Taniguchi M, Kudo T et al. (2001). The unfolded protein response and Alzheimer′s disease. Biochim Biophys Acta 1536: 85–96.
Jean JC, Oakes SM, Joyce-Brady M . (1999). The Bax inhibitor-1 gene is differentially regulated in adult testis and developing lung by two alternative TATA-less promoters. Genomics 57: 201–208.
Kim HR, Lee GH, Cho EY, Chae SW, Ahn T, Chae HJ . (2009). Bax inhibitor 1 regulates ER-stress-induced ROS accumulation through the regulation of cytochrome P450 2E1. J Cell Sci 122: 1126–1133.
Kim HR, Lee GH, Ha KC, Ahn T, Moon JY, Lee BJ et al. (2008). Bax Inhibitor-1 Is a pH-dependent regulator of Ca2+ channel activity in the endoplasmic reticulum. J Biol Chem 283: 15946–15955.
Kim R, Emi M, Tanabe K, Murakami S . (2006). Role of the unfolded protein response in cell death. Apoptosis 11: 5–13.
Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T . (2002). Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol 50: 343–352.
Kohno K . (2010). Stress-sensing mechanisms in the unfolded protein response: similarities and differences between yeast and mammals. J Biochem 147: 27–33.
Krajewski S, Krajewska M, Turner BC, Pratt C, Howard B, Zapata JM et al. (1999). Prognostic significance of apoptosis regulators in breast cancer. Endocr Relat Cancer 6: 29–40.
Kuo TH, Kim HR, Zhu L, Yu Y, Lin HM, Tsang W . (1998). Modulation of endoplasmic reticulum calcium pump by Bcl-2. Oncogene 17: 1903–1910.
Kurokawa H, Nishio K, Fukumoto H, Tomonari A, Suzuki T, Saijo N . (1999). Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol Rep 6: 33–37.
Kvansakul M, Yang H, Fairlie WD, Czabotar PE, Fischer SF, Perugini MA et al. (2008). Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ 15: 1564–1571.
Lebiedzinska M, Szabadkai G, Jones AW, Duszynski J, Wieckowski MR . (2009). Interactions between the endoplasmic reticulum, mitochondria, plasma membrane and other subcellular organelles. Int J Biochem Cell Biol 41: 1805–1816.
Lee GH, Ahn T, Kim DS, Park SJ, Lee YC, Yoo WH et al. (2010a). Bax inhibitor 1 increases cell adhesion through actin polymerization: involvement of calcium and actin binding. Mol Cell Biol 30: 1800–1813.
Lee GH, Kim HK, Chae SW, Kim DS, Ha KC, Cuddy M et al. (2007). Bax inhibitor-1 regulates endoplasmic reticulum stress-associated reactive oxygen species and heme oxygenase-1 expression. J Biol Chem 282: 21618–21628.
Lee GH, Yan C, Shin SJ, Hong SC, Ahn T, Moon A et al. (2010b). BAX inhibitor-1 enhances cancer metastasis by altering glucose metabolism and activating the sodium-hydrogen exchanger: the alteration of mitochondrial function. Oncogene 29: 2130–2141.
Lima RT, Martins LM, Guimaraes JE, Sambade C, Vasconcelos MH . (2004). Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer Gene Ther 11: 309–316.
Lisbona F, Rojas-Rivera D, Thielen P, Zamorano S, Todd D, Martinon F et al. (2009). BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1alpha. Mol Cell 33: 679–691.
Madeo F, Herker E, Maldener C, Wissing S, Lachelt S, Herlan M et al. (2002). A caspase-related protease regulates apoptosis in yeast. Mol Cell 9: 911–917.
Nieto N, Friedman SL, Cederbaum AI . (2002). Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology 35: 62–73.
Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S et al. (2006). Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 26: 9220–9231.
Plopper GE, McNamee HP, Dike LE, Bojanowski K, Ingber DE . (1995). Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell 6: 1349–1365.
Ravi R, Bedi A . (2002). Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L). Cancer Res 62: 1583–1587.
Reshkin SJ, Bellizzi A, Caldeira S, Albarani V, Malanchi I, Poignee M et al. (2000). Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J 14: 2185–2197.
Rizzuto R, Pinton P, Ferrari D, Chami M, Szabadkai G, Magalhaes PJ et al. (2003). Calcium and apoptosis: facts and hypotheses. Oncogene 22: 8619–8627.
Rong J, Chen L, Toth JI, Tcherpakov M, Petroski MD, Reed JC . (2011). BAR, an endoplasmic reticulum-associated E3 ubiquitin ligase, modulates BI-1 protein stability and function in ER stress. J Biol Chem 206: 1453–1463.
Rong YP, Bultynck G, Aromolaran AS, Zhong F, Parys JB, De Smedt H et al. (2009). The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc Natl Acad Sci USA 106: 14397–14402.
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. (1998). Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675–1687.
Schmits R, Cochlovius B, Treitz G, Regitz E, Ketter R, Preuss KD et al. (2002). Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas. Int J Cancer 98: 73–77.
Shiraishi H, Okamoto H, Yoshimura A, Yoshida H . (2006). ER stress-induced apoptosis and caspase-12 activation occurs downstream of mitochondrial apoptosis involving Apaf-1. J Cell Sci 119: 3958–3966.
Srinivasula SM, Ahmad M, MacFarlane M, Luo Z, Huang Z, Fernandes-Alnemri T et al. (1998). Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits. J Biol Chem 273: 10107–10111.
Tanaka R, Ishiyama T, Uchihara T, Inadome Y, Iijima T, Morishita Y et al. (2006). Expression of the Bax inhibitor-1 gene in pulmonary adenocarcinoma. Cancer 106: 648–653.
Tannock IF, Rotin D . (1989). Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49: 4373–4384.
Urano W, Taniguchi A, Anzai N, Inoue E, Kanai Y, Yamanaka M et al. (2010). Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann Rheum Dis 69: 1232–1234.
Wahl ML, Pooler PM, Briand P, Leeper DB, Owen CS . (2000). Intracellular pH regulation in a nonmalignant and a derived malignant human breast cell line. J Cell Physiol 183: 373–380.
Wang E, Marcotte R, Petroulakis E . (1999). Signaling pathway for apoptosis: a racetrack for life or death. J Cell Biochem 75 (Suppl 32–33): 95–102.
Wyllie AH . (2010). ‘Where, O death, is thy sting?’ A brief review of apoptosis biology. Mol Neurobiol 42: 4–9.
Xu C, Bailly-Maitre B, Reed JC . (2005). Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 115: 2656–2664.
Xu Q, Reed JC . (1998). Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol Cell 1: 337–346.
Yang L, Cao Z, Yan H, Wood WC . (2003). Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 63: 6815–6824.